Biological markers in peritoneal effluent: are they useful?
Krediet
Raymond T
RT
Division of Nephrology, Department of Medicine, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands. M.A.Zeeman@amc.uva.nl
D015415:Biomarkers / Q000097:blood; D015314:Dialysis Solutions / Q000009:adverse effects* / Q000494:pharmacology; D005260:Female; D006801:Humans; D006820:Hyaluronic Acid / Q000032:analysis; D008134:Long-Term Care; D008297:Male; D010530:Peritoneal Dialysis / Q000009:adverse effects* / Q000379:methods; D010538:Peritonitis / Q000175:diagnosis* / Q000209:etiology; D010743:Phospholipids / Q000032:analysis; D011347:Procollagen / Q000032:analysis; D011379:Prognosis; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D012720:Severity of Illness Index
D015415:Biomarkers; D015314:Dialysis Solutions; D010743:Phospholipids; D011347:Procollagen; D006820:Hyaluronic Acid